NTLA — Intellia Therapeutics, Inc. | XLV Holdings | StockAdder

(NTLA)

Intellia Therapeutics, Inc.

Live chart and latest NTLA stock news.

Sector ETF → XLV Health Care Select

Chart powered byTradingView— professional charts for every trader.Try it free →

NTLA News

Intellia Therapeutics

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mar 6, 2026 Yahoo Finance

Baird Updates Intellia Therapeutics, Inc. (NTLA)’s Financial Model Following Nex-Z Clinical Hold Removal

Feb 2, 2026 Stock Titan

Intellia (NASDAQ: NTLA) revises bylaws on shareholder notices and federal forums

Apr 10, 2026 The Globe and Mail

Intellia Therapeutics Adopts Fourth Amended and Restated Bylaws

Apr 11, 2026 Quiver Quantitative

Intellia Therapeutics Stock (NTLA) Opinions on Clinical Trial Suspension

Nov 18, 2025 Intellia Therapeutics

Intellia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Feb 6, 2026 Yahoo Finance

Intellia Therapeutics, Inc. (NTLA): A Bear Case Theory

Dec 4, 2025 Stock Titan

Intellia Therapeutics (NTLA) — Vanguard disaggregates holdings, parent reports 0 shares

Mar 27, 2026 Intellia Therapeutics

Intellia Therapeutics Announces Third Quarter 2025 Financial Results and Recent Updates

Nov 6, 2025 Yahoo Finance

Intellia Therapeutics, Inc. (NTLA): A Bull Case Theory

Feb 28, 2026 Stock Titan

13 new Intellia employees get 67,150 stock units over 3 years

Apr 3, 2026 Yahoo Finance

Intellia Therapeutics (NTLA) Is Up 6.5% After ARK’s Stock Buying And JPM Pipeline Update – Has The Bull Case Changed?

Jan 20, 2026 Yahoo Finance

Is Intellia Therapeutics (NTLA) Pricing Make Sense After Recent 35% Monthly Surge

Jan 19, 2026 Yahoo Finance

Assessing Intellia Therapeutics (NTLA) Valuation After Recent Share Price Rebound and Conflicting Fair Value Signals

Jan 19, 2026 Yahoo Finance

Intellia Therapeutics (NTLA) Soars 19.7%: Is Further Upside Left in the Stock?